Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory and Relapsed Primary CNS Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06931652
What this trial is testing

Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

Who this might be right for
Primary CNS Lymphoma (PCNSL)
The Lymphoma Academic Research Organisation 60
Testing effectiveness (Phase 2)UnknownNCT04066920
What this trial is testing

IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma
Deok-Hwan Yang 30
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Testing effectiveness (Phase 2)Ended earlyNCT01973062
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma

Who this might be right for
Primary Central Nervous System Non-Hodgkin Lymphoma
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05485753
What this trial is testing

GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 7
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT03328078
What this trial is testing

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Who this might be right for
Relapsed Hematologic MalignancyRefractory Hematologic MalignancyRelapsed Primary Central Nervous System Lymphoma+1 more
Curis, Inc. 152
Not applicableLooking for participantsNCT07074470
What this trial is testing

Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Looking for participantsNCT07082868
What this trial is testing

Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Primary Central Nervous System LymphomaRelapsed Primary Central Nervous System Lymphoma+4 more
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT04073147
What this trial is testing

Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma
Klinikum Stuttgart 4
Testing effectiveness (Phase 2)Study completedNCT01647971
What this trial is testing

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins LymphomaB-cell LymphomaWaldenstrom's Macroglobulinemia+4 more
TG Therapeutics, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Testing effectiveness (Phase 2)Study completedNCT00066248
What this trial is testing

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

Who this might be right for
Brain TumorCentral Nervous System TumorsCachexia+5 more
University of South Florida 70